![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
LG Jones, PM McDonough and JH Brown
Department of Pharmacology, University of California San Diego, La Jolla 92093.
Thrombin stimulates polyphosphoinositide hydrolysis in embryonic chick heart cells and in 1321N1 astrocytoma cells and increases intracellular Ca2+ in the 1321N1 cells. The serine protease trypsin mimics these actions in a dose-dependent fashion, whereas the proteolytically inactive thrombin derivatives diisopropyl fluorophosphate-thrombin (DIP- thrombin) and D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone- thrombin (PPACK-thrombin) are ineffective in this regard. The phosphoinositide responses to thrombin or trypsin and the muscarinic agonist carbachol are additive, but no additivity is observed between the responses to thrombin and trypsin. Unlike the response to carbachol, the phosphoinositide and Ca2+ responses to thrombin and trypsin desensitize, with no recovery of the calcium response even when Ca2+ stores are replenished. Cross-desensitization of phospholipase C activation and calcium mobilization between these proteases is also observed. In addition, PPACK-thrombin, which elicits no response itself, effectively inhibits trypsin-stimulated phosphoinositide hydrolysis. It is proposed that thrombin and trypsin act through the same receptor. Proteolysis appears to be important in the mechanism by which these agonists elicit phosphoinositide hydrolysis, calcium mobilization, and, perhaps, subsequent receptor desensitization.
This article has been cited by other articles:
|
|
 |
|
  T. W. Stief Thrombin Generation by Exposure of Blood to Endotoxin: A Simple Model to Study Disseminated Intravascular Coagulation Clinical and Applied Thrombosis/Hemostasis, April 1, 2006; 12(2): 137 - 161. [Abstract] [PDF]
|
|
|
|
 |
|
 T. A. Cheema, C. E. Ward, and S. K. Fisher Subnanomolar Concentrations of Thrombin Enhance the Volume-Sensitive Efflux of Taurine from Human 1321N1 Astrocytoma Cells J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 755 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Majumdar, T. M. Seasholtz, D. Goldstein, P. de Lanerolle, and J. H. Brown Requirement for Rho-mediated Myosin Light Chain Phosphorylation in Thrombin-stimulated Cell Rounding and Its Dissociation from Mitogenesis J. Biol. Chem., April 24, 1998; 273(17): 10099 - 10106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
BrianD. Blackhart, K. Emilsson, D. Nguyen, W. Teng, ArnoldJ. Martelli, S. Nystedt, J. Sundelin, and RobertM. Scarborough Ligand Cross-reactivity within the Protease-activated Receptor Family J. Biol. Chem., July 12, 1996; 271(28): 16466 - 16471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Aragay, L. R. Collins, G. R. Post, A. J. Watson, J. R. Feramisco, J. H. Brown, and M. I. Simon G[IMAGE] Requirement for Thrombin-stimulated Gene Expression and DNA Synthesis in 1321N1 Astrocytoma Cells J. Biol. Chem., August 25, 1995; 270(34): 20073 - 20077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Woolkalis, T. M. DeMelfiJr., N. Blanchard, J. A. Hoxie, and L. F. Brass Regulation of Thrombin Receptors on Human Umbilical Vein Endothelial Cells J. Biol. Chem., April 28, 1995; 270(17): 9868 - 9875. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
